| Neuland Laboratories Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524558 |
NSE Symbol : NEULANDLAB |
P/E(TTM) : 71.11 |
|
ISIN Demat : INE794A01010 |
Div & Yield% : 0.17 |
EPS(TTM) : 280.77 |
|
Book Value(₹) : 1,453.59 |
Market Cap(₹Cr) : 25,614.49 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 641.58 | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 641.58 | 776.25 | 439.71 | 514.27 | 292.75 | 328.36 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 8.49 | 12.46 | 8.05 | 1.80 | 7.86 | 7.46 |
| Total Income | 650.07 | 788.71 | 447.76 | 516.07 | 300.61 | 335.82 |
| Total Expenditure | 419.00 | 469.35 | 362.78 | 359.15 | 258.46 | 277.61 |
| PBIDT | 231.07 | 319.36 | 84.98 | 156.92 | 42.15 | 58.22 |
| Interest | 6.97 | 7.23 | 6.79 | 5.34 | 4.58 | 2.35 |
| PBDT | 224.10 | 312.13 | 78.19 | 151.58 | 37.57 | 55.87 |
| Depreciation | 26.56 | 25.09 | 23.92 | 22.54 | 20.19 | 16.89 |
| Tax | 50.88 | 76.80 | 15.21 | 32.51 | 4.37 | 5.94 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.71 | -2.28 | -1.35 | 0.07 | -0.70 | 5.31 |
| Reported Profit After Tax | 147.36 | 212.52 | 40.42 | 96.46 | 13.71 | 27.73 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 147.36 | 212.52 | 40.42 | 96.46 | 13.71 | 27.73 |
| EPS (Unit Curr.) | 114.86 | 165.65 | 31.50 | 75.18 | 10.68 | 21.62 |
| EPS (Adj) (Unit Curr.) | 114.86 | 165.65 | 31.50 | 75.18 | 10.68 | 21.62 |
| Calculated EPS (Unit Curr.) | 114.23 | 164.74 | 31.33 | 74.77 | 10.63 | 21.50 |
| Calculated EPS (Adj) (Unit Curr.) | 114.23 | 164.74 | 31.33 | 74.77 | 10.63 | 21.50 |
| Calculated EPS (Ann.) (Unit Curr.) | 456.92 | 658.96 | 125.31 | 299.09 | 42.50 | 85.99 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 456.92 | 658.96 | 125.31 | 299.09 | 42.50 | 85.99 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 | 12.90 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 36.02 | 41.14 | 19.33 | 30.51 | 14.40 | 17.73 |
| PBDTM(%) | 34.93 | 40.21 | 17.78 | 29.47 | 12.83 | 17.01 |
| PATM(%) | 22.97 | 27.38 | 9.19 | 18.76 | 4.68 | 8.44 |
